Trualt Bioenergy IPO Closes with Massive 71.92x Oversubscription: GMP, Key Details, and Should You Invest?

In the dynamic world of Indian stock markets, IPOs in the sustainable energy sector are drawing massive attention amid India's push for green fuels. The Trualt Bioenergy IPO, which closed on September 29, 2025, exemplifies this trend with an astounding oversubscription of 71.92 times. This bioenergy player's public offering has sparked investor frenzy, driven by its position in the ethanol and compressed biogas (CBG) markets. If you're wondering about the hype, subscription stats, grey market premium (GMP), and whether it's a smart bet, this in-depth analysis breaks it all down. We'll cover the company's background, financial health, risks, and expert recommendations to help you decide.

What is Trualt Bioenergy? A Quick Company Overview

Trualt Bioenergy Limited, founded in December 1988 and headquartered in Bengaluru, stands as one of India's leading ethanol producers with an installed capacity of 2,000 kilo litres per day (KLPD), capturing about 3.6% market share. The company isn't just about biofuels – it also manufactures power, auto, and inverter-duty transformers, supplying across 19 states and three union territories. With five manufacturing facilities (four operational), Trualt has delivered over 4,400 transformers totaling 94,000 MVA capacity.

Expanding into next-gen areas like 2G ethanol, sustainable aviation fuel (SAF), and CBG, Trualt has strategic partnerships with giants like GAIL and Sumitomo. This diversification positions it well in India's renewable energy boom, aligning with government policies promoting biofuels to reduce fossil fuel dependence.

IPO Subscription Status: Breaking Down the Numbers

The IPO, open from September 24 to 29, 2025, saw overwhelming demand. By the closing day, it received bids for 88.85 crore shares against 1.23 crore on offer, resulting in a 71.92 times overall subscription. Earlier on Day 3 (as of 1:00 PM), it was already at 10.55 times, with non-institutional investors (NIIs) leading at 35.73 times, followed by retail at 5.12 times and qualified institutional buyers (QIBs) at 1.15 times.

This high subscription reflects strong investor confidence in the bioenergy sector, especially with India's ethanol blending targets aiming for 20% by 2025. For context, the anchor book alone raised ₹251.78 crore from 19 investors at ₹496 per share.

Price Band, Issue Size, and Lot Details

• Price Band: ₹472 to ₹496 per equity share.
• Issue Size: Total ₹839.28 crore, including a fresh issue of 1.51 crore shares (₹750 crore) and an offer-for-sale (OFS) of 0.18 crore shares (₹89.28 crore).
• Lot Size: Minimum 30 shares for retail investors, requiring an investment of about ₹14,880 at the upper band.

The book-running lead manager is Dam Capital Advisors Ltd., with Bigshare Services Pvt. Ltd. as the registrar.

Use of Proceeds: Fueling Growth

Proceeds from the fresh issue will fund:

• ₹150.68 crore for capex to convert a unit into a 300 KLPD multi-feed ethanol plant (using grains like maize and rice), with production starting January 2026.
• ₹425 crore for working capital.
• Balance for general corporate purposes.

This expansion underscores Trualt's focus on scaling biofuel production amid rising demand.

Financial Performance: Strong Growth Trajectory

Trualt's financials are impressive, with revenue, EBITDA, and PAT growing at CAGRs of 58%, 72%, and 103% respectively from FY22 to FY25. For the year ended March 31, 2025, it reported a net profit of ₹146.64 crore on sales of ₹1,907.72 crore. At the upper price band, the IPO is valued at a FY25 PE multiple of 29.0x, which seems reasonable given the sector's potential.

Grey Market Premium (GMP) and Listing Expectations

The GMP stood at ₹109, suggesting an estimated listing price of ₹605 – a 21.98% premium over the ₹496 upper band. Allotment is expected on September 30, 2025, with listing on NSE and BSE on October 3, 2025. While GMP indicates positive sentiment, remember it's unofficial and volatile.

Risks to Consider

Despite the buzz, risks include dependency on government policies for biofuels, raw material price fluctuations (e.g., grains), and the need for ongoing tech innovation in a competitive sector. The bioenergy industry requires strategic planning to mitigate regulatory and market shifts.

Analyst Recommendations: A Buy for Long-Term Investors?

Brokers like Reliance Securities and SBI Securities recommend subscribing, highlighting Trualt's diversified portfolio, robust financials, and alignment with India's sustainable energy goals. It's seen as a play on the growing demand for green fuels, but short-term volatility post-listing is possible.

For more on IPO strategies, check our previous posts: Ultimate Guide to IPO Subscriptions in India and Top Sustainable Energy Stocks to Watch. Externally, refer to SEBI's guidelines on biofuels for deeper insights.

Conclusion: Is Trualt Bioenergy IPO Worth Your Portfolio?

With 71.92x oversubscription, solid financials, and a GMP signaling gains, Trualt Bioenergy IPO looks promising for investors eyeing the green energy wave. However, weigh the risks and consult a financial advisor. If you're in for long-term growth in biofuels, this could be a winner. What are your thoughts on bioenergy IPOs? Drop a comment below!